Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 3601708, 10 pages
https://doi.org/10.1155/2017/3601708
Research Article

Quantitative Proteomic Analysis of Hepatic Tissue of T2DM Rhesus Macaque

Tingfu Du,1,2,3 Shuaiyao Lu,1,3 Qinfang Jiang,1,3 Yun Li,1,3 and Kaili Ma1,2,3

1Center for Drug Safety Evaluation and Research, Institute of Medical Biology, Chinese Academy of Medical Sciences, Kunming 650118, China
2Medical Primate Research Center & Neuroscience Center, Chinese Academy of Medical Sciences, Beijing 100005, China
3Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Diseases, Kunming 650118, China

Correspondence should be addressed to Kaili Ma; moc.liamg@cmuplkm

Received 7 September 2017; Accepted 9 November 2017; Published 14 December 2017

Academic Editor: Janet H. Southerland

Copyright © 2017 Tingfu Du et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Al-Awar, K. Kupai, M. Veszelka et al., “Experimental diabetes mellitus in different animal models,” Journal of Diabetes Research, vol. 2016, Article ID 9051426, 12 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. O. R. Temneanu, L. M. Trandafir, and M. R. Purcarea, “Type 2 diabetes mellitus in children and adolescents: a relatively new clinical problem within pediatric practice,” Journal of Medicine and Life, vol. 9, no. 3, pp. 235–239, 2016. View at Google Scholar
  3. T. P. Solomon, S. N. Sistrun, R. K. Krishnan et al., “Exercise and diet enhance fat oxidation and reduce insulin resistance in older obese adults,” Journal of Applied Physiology, vol. 104, no. 5, pp. 1313–1319, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. N. A. Calcutt, M. E. Cooper, T. S. Kern, and A. M. Schmidt, “Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials,” Nature Reviews Drug Discovery, vol. 8, no. 5, pp. 417–430, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. A. A. Korish, “The antidiabetic action of camel milk in experimental type 2 diabetes mellitus: an overview on the changes in incretin hormones, insulin resistance, and inflammatory cytokines,” Hormone and Metabolic Research, vol. 46, no. 6, pp. 404–411, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Dong, H. Ni, M. Wu, Z. Tang, M. Halim, and D. Shi, “ROS-mediated glucose metabolic reprogram induces insulin resistance in type 2 diabetes,” Biochemical and Biophysical Research Communications, vol. 476, no. 4, pp. 204–211, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. C. C. Sestile, J. C. Maraschin, M. P. Rangel, R. K. Cuman, and E. A. Audi, “Antidepressant-like effect of insulin in streptozotocin-induced type 2 diabetes mellitus rats,” Basic & Clinical Pharmacology & Toxicology, vol. 119, no. 3, pp. 243–248, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Dong, H. Xu, H. Xu et al., “Nesfatin-1 stimulates fatty-acid oxidation by activating AMP-activated protein kinase in STZ-induced type 2 diabetic mice,” PLoS One, vol. 8, no. 12, article e83397, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Y. Lu, S. D. Qi, Y. Zhao et al., “Type 2 diabetes mellitus non-genetic rhesus monkey model induced by high fat and high sucrose diet,” Experimental and Clinical Endocrinology & Diabetes, vol. 123, no. 1, pp. 19–26, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Lopez-Villar, G. A. Martos-Moreno, J. A. Chowen, S. Okada, J. J. Kopchick, and J. Argente, “A proteomic approach to obesity and type 2 diabetes,” Journal of Cellular and Molecular Medicine, vol. 19, no. 7, pp. 1455–1470, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Ma, C. Yang, Y. Tao, H. Zhou, and Y. Wang, “Recent technological developments in proteomics shed new light on translational research on diabetic microangiopathy,” The FEBS Journal, vol. 280, no. 22, pp. 5668–5681, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Murri, M. Insenser, M. Luque, F. J. Tinahones, and H. F. Escobar-Morreale, “Proteomic analysis of adipose tissue: informing diabetes research,” Expert Review of Proteomics, vol. 11, no. 4, pp. 491–502, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Oh, D. Lee, W. Kim, B. S. Han, S. C. Lee, and K. H. Bae, “Metabolic adaptation in obesity and type II diabetes: myokines, adipokines and hepatokines,” International Journal of Molecular Sciences, vol. 18, no. 1, p. 8, 2017. View at Publisher · View at Google Scholar
  14. N. Stefan and H. U. Haring, “The role of hepatokines in metabolism,” Nature Reviews Endocrinology, vol. 9, no. 3, pp. 144–152, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Bartoli, G. P. Fra, and S. G. Carnevale, “The oral glucose tolerance test (OGTT) revisited,” European Journal of Internal Medicine, vol. 22, no. 1, pp. 8–12, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. E. H. Leiter, “Selecting the “right” mouse model for metabolic syndrome and type 2 diabetes research,” Methods in Molecular Biology, vol. 560, pp. 1–17, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. D. S. Paul, F. S. Walton, R. J. Saunders, and M. Styblo, “Characterization of the impaired glucose homeostasis produced in C57BL/6 mice by chronic exposure to arsenic and high-fat diet,” Environmental Health Perspectives, vol. 119, no. 8, pp. 1104–1109, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Priego, J. Sanchez, P. Oliver, A. Palou, and C. Pico, “Sex-dependent changes of hypothalamic neuropeptides in response to a prolonged high-fat diet,” Genes & Nutrition, vol. 2, no. 1, pp. 127-128, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. L. D. Pound, P. Kievit, and K. L. Grove, “The nonhuman primate as a model for type 2 diabetes,” Current Opinion in Endocrinology, Diabetes, and Obesity, vol. 21, no. 2, pp. 89–94, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Loureiro, A. Martinez-Aguayo, C. Campino, C. Carvajal, C. Fardella, and H. García, “Hepatic steatosis as diabetes type 2 predictor,” Nutrición Hospitalaria, vol. 29, no. 2, pp. 350–358, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. P. Zhou and V. E. Grill, “Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle,” The Journal of Clinical Investigation, vol. 93, no. 2, pp. 870–876, 1994. View at Publisher · View at Google Scholar
  22. J. J. Milburn, H. Hirose, Y. H. Lee et al., “Pancreatic β-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids,” The Journal of Biological Chemistry, vol. 270, no. 3, pp. 1295–1299, 1995. View at Publisher · View at Google Scholar
  23. A. Kotronen, L. Juurinen, M. Tiikkainen, S. Vehkavaara, and H. Yki-Jarvinen, “Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes,” Gastroenterology, vol. 135, no. 1, pp. 122–130, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Gastaldelli, K. Cusi, M. Pettiti et al., “Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects,” Gastroenterology, vol. 133, no. 2, pp. 496–506, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. I. A. Leclercq, S. M. A. Da, B. Schroyen, N. Van Hul, and A. Geerts, “Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences,” Journal of Hepatology, vol. 47, no. 1, pp. 142–156, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Han, C. Hu, L. Wang et al., “Duodenal-jejunal bypass surgery suppresses hepatic de novo lipogenesis and alleviates liver fat accumulation in a diabetic rat model,” Obesity Surgery, vol. 24, no. 12, pp. 2152–2160, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. J. R. Bain, R. D. Stevens, B. R. Wenner, O. Ilkayeva, D. M. Muoio, and C. B. Newgard, “Metabolomics applied to diabetes research: moving from information to knowledge,” Diabetes, vol. 58, no. 11, pp. 2429–2443, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. T. J. Wang, M. G. Larson, R. S. Vasan et al., “Metabolite profiles and the risk of developing diabetes,” Nature Medicine, vol. 17, no. 4, pp. 448–453, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Nagao and M. Yamakado, “The role of amino acid profiles in diabetes risk assessment,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 19, no. 5, pp. 328–335, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Le Floc’h, W. Otten, and E. Merlot, “Tryptophan metabolism, from nutrition to potential therapeutic applications,” Amino Acids, vol. 41, no. 5, pp. 1195–1205, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Chen, X. Zheng, X. Ma et al., “Tryptophan predicts the risk for future type 2 diabetes,” PLoS One, vol. 11, no. 9, article e162192, 2016. View at Google Scholar
  32. J. M. Mudry, P. S. Alm, S. Erhardt et al., “Direct effects of exercise on kynurenine metabolism in people with normal glucose tolerance or type 2 diabetes,” Diabetes/Metabolism Research and Reviews, vol. 32, no. 7, pp. 754–761, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Cappelli, S. Silvestri, S. Tumini et al., “A new de novo mutation in the GCK gene causing MODY2,” Diabetes Research and Clinical Practice, vol. 93, no. 1, pp. e41–e43, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. R. A. Haeusler, S. Camastra, B. Astiarraga, M. Nannipieri, M. Anselmino, and E. Ferrannini, “Decreased expression of hepatic glucokinase in type 2 diabetes,” Molecular Metabolism, vol. 4, no. 3, pp. 222–226, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. J. F. Caro, S. Triester, V. K. Patel, E. B. Tapscott, N. L. Frazier, and G. L. Dohm, “Liver glucokinase: decreased activity in patients with type II diabetes,” Hormone and Metabolic Research, vol. 27, no. 01, pp. 19–22, 1995. View at Publisher · View at Google Scholar
  36. J. N. Clore, J. Stillman, and H. Sugerman, “Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes,” Diabetes, vol. 49, no. 6, pp. 969–974, 2000. View at Publisher · View at Google Scholar
  37. S. Jha, S. Siddiqui, S. Waghdhare et al., “Identification of a novel glucokinase mutation in an Indian woman with GCK-MODY,” Lancet Diabetes & Endocrinology, vol. 4, no. 4, p. 302, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. M. A. Navas, M. Galan, O. Vincent et al., “Gene symbol: GCK. Disease: diabetes, MODY,” Human Genetics, vol. 119, no. 3, p. 363, 2006. View at Google Scholar
  39. L. Agius, “Glucokinase and molecular aspects of liver glycogen metabolism,” The Biochemical Journal, vol. 414, no. 1, pp. 1–18, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Tang, H. Ye, Q. Hong et al., “Elevated CpG island methylation of GCK gene predicts the risk of type 2 diabetes in Chinese males,” Gene, vol. 547, no. 2, pp. 329–333, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Bello-Perez, A. Falco, R. Medina et al., “Structure and functionalities of the human c-reactive protein compared to the zebrafish multigene family of c-reactive-like proteins,” Developmental and Comparative Immunology, vol. 69, pp. 33–40, 2017. View at Publisher · View at Google Scholar
  42. M. S. Al-Zahrani, B. M. Abozor, and K. H. Zawawi, “The relationship between periapical lesions and the serum levels of glycosylated hemoglobin and C-reactive protein in type 2 diabetic patients,” Saudi Medical Journal, vol. 38, no. 1, pp. 36–40, 2017. View at Publisher · View at Google Scholar
  43. S. M. Lima, D. C. Grisi, E. M. Kogawa et al., “Diabetes mellitus and inflammatory pulpal and periapical disease: a review,” International Endodontic Journal, vol. 46, no. 8, pp. 700–709, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Dehghan, I. Kardys, M. P. de Maat et al., “Genetic variation, C-reactive protein levels, and incidence of diabetes,” Diabetes, vol. 56, no. 3, pp. 872–878, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Pan, Y. Wang, J. M. Yuan, and W. P. Koh, “High-sensitive C-reactive protein and risk of incident type 2 diabetes: a case-control study nested within the Singapore Chinese Health Study,” BMC Endocrine Disorders, vol. 17, no. 1, p. 8, 2017. View at Publisher · View at Google Scholar
  46. J. Kasznicki, A. Sliwinska, M. Kosmalski, A. Merecz, I. Majsterek, and J. Drzewoski, “Genetic polymorphisms (Pro197Leu of Gpx1, +35A/C of SOD1, −262C/T of CAT), the level of antioxidant proteins (GPx1, SOD1, CAT) and the risk of distal symmetric polyneuropathy in Polish patients with type 2 diabetes mellitus,” Advances in Medical Sciences, vol. 61, no. 1, pp. 123–129, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Ozkul, M. Ayhan, C. Yenisey, A. Akyol, E. Guney, and F. A. Ergin, “The role of oxidative stress and endothelial injury in diabetic neuropathy and neuropathic pain,” Neuro Endocrinology Letters, vol. 31, no. 2, pp. 261–264, 2010. View at Google Scholar
  48. M. H. Ghattas and D. M. Abo-Elmatty, “Association of polymorphic markers of the catalase and superoxide dismutase genes with type 2 diabetes mellitus,” DNA and Cell Biology, vol. 31, no. 11, pp. 1598–1603, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Xu, Y. Wang, J. Y. Xu et al., “Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome,” Clinical Chemistry, vol. 52, no. 3, pp. 405–413, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Furuhashi, S. Saitoh, K. Shimamoto, and T. Miura, “Fatty acid-binding. Protein 4 (FABP4): pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases,” Clinical Medicine Insights Cardiology, vol. 8, Supplement 3, pp. 23–33, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. K. T. Uysal, L. Scheja, S. M. Wiesbrock, S. Bonner-Weir, and G. K. Hotamisligil, “Improved glucose and lipid metabolism in genetically obese mice lacking aP2,” Endocrinology, vol. 141, no. 9, pp. 3388–3396, 2000. View at Publisher · View at Google Scholar
  52. A. Cabre, I. Lazaro, J. Girona et al., “Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients,” Atherosclerosis, vol. 195, no. 1, pp. e150–e158, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. D. Su, C. L. Zhang, Y. C. Gao et al., “Gene expression and correlation of pten and fabp4 in liver, muscle, and adipose tissues of type 2 diabetes rats,” Medical Science Monitor, vol. 21, pp. 3616–3621, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. G. A. Gomez, R. M. Rivera, A. C. Gomez, O. D. Rodriguez, and A. C. Alvarez, “Myeloperoxidase is associated with insulin resistance and inflammation in overweight subjects with first-degree relatives with type 2 diabetes mellitus,” Diabetes and Metabolism Journal, vol. 39, no. 1, pp. 59–65, 2015. View at Publisher · View at Google Scholar · View at Scopus
  55. M. T. Marin, P. S. Dasari, J. B. Tryggestad, C. E. Aston, A. M. Teague, and K. R. Short, “Oxidized HDL and LDL in adolescents with type 2 diabetes compared to normal weight and obese peers,” Journal of Diabetes and its Complications, vol. 29, no. 5, pp. 679–685, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Kone, T. J. Pullen, G. Sun et al., “LKB1 and AMPK differentially regulate pancreatic beta-cell identity,” The FASEB Journal, vol. 28, no. 11, pp. 4972–4985, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. E. K. Ainscow, C. Zhao, and G. A. Rutter, “Acute overexpression of lactate dehydrogenase-A perturbs beta-cell mitochondrial metabolism and insulin secretion,” Diabetes, vol. 49, no. 7, pp. 1149–1155, 2000. View at Publisher · View at Google Scholar